Skip directly to site content Skip directly to page options Skip directly to A-Z link


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
														Search
		×
			NIOSH
			NIOSH
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


The National Institute for Occupational Safety and Health (NIOSH)


Facebook
        Twitter
        LinkedIn
        Syndicate





HEXYLENE GLYCOL								Related Pages
										*OSHA comments from the January 19, 1989 Final Rule on Air Contaminants Project extracted from 54FR2332 et. seq. This rule was remanded by the U.S. Circuit Court of Appeals and the limits are not currently in force.*
**CAS:** 107-41-5; **Chemical Formula:** (CH3)2-COHCH2-CHOH-CH3
OSHA previously had no limit for hexylene glycol. Based on the ACGIH recommendation, OSHA proposed a ceiling limit of 25 ppm for this liquid, which has a mild, sweetish odor. NIOSH (Ex. 8-47, Table N1) concurred with this proposed limit, and the final rule establishes it.
In mice, the LD(50) for hexylene glycol is reported to be 3.8 ml/kg, and it is reported to be 4.79 g/kg in rats. A single dose of 2.0 ml/kg induced hypnosis in mice. Undiluted hexylene glycol instilled into the rabbit eye caused irritation and corneal injury (Smyth and Carpenter 1948/Ex. 1-375).
The Shell Chemical Corporation has reported that oral administration of hexylene glycol can cause nervous system depression that is manifested by an initial state of excitation, followed by deep depression (Shell Chemical Corporation, as cited in ACGIH 1986/Ex. 1-3, p. 309). When the liquid is applied to the skin, mild to moderate irritation occurs, although skin absorption does not. At high concentrations, hexylene glycol vapors evoke a strong sensory response: a five-minute exposure at 1000 ppm produced eye irritation and throat and respiratory discomfort. At concentrations of 50 ppm for 15 minutes, slight eye irritation was reported (ACGIH 1986/Ex. 1-3, p. 309).
Mr. Melampy, Counsel to the ILMA, commented that the proposed 25-ppm ceiling limit “is far below the hazard levels found to exist...,” given that exposures to hexylene glycol concentrations of 50 ppm for brief periods of time cause only slight eye irritation. OSHA does not agree with the assessment that a 25-ppm ceiling limit is too low. As discussed earlier in this section, OSHA has determined that no employee should be subjected to mucous membrane or respiratory irritation caused by exposure to toxic agents and that this effect represents material impairment of health and adversely affects the well-being and functional capacity of employees. For hexylene glycol, 50 ppm represents an adverse-effect level, and establishing the limit at this level would not be sufficiently protective. OSHA also concludes that 25 ppm is a reasonable level at which to establish the PEL; this level provides some margin against this substance’s irritant effects. Therefore, OSHA finds that establishing a 25-ppm ceiling limit for hexylene glycol is necessary to reduce the risks of eye and respiratory irritation, which occur at exposure levels above the new PEL.
										
							
								Page last reviewed:  September 28, 2011						Content source:  	National Institute for Occupational Safety and Health NIOSH
1988 OSHA PEL Project Documentation
Index of Chemical Names
Index of CAS Numbers Follow NIOSH Facebook
Pinterest
Twitter
YouTube
 NIOSH Homepage NIOSH A-Z
Workplace Safety & Health Topics
Publications and Products
Programs
Contact NIOSH


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue